This is accompanied by broader reduction of type 2 inflammation, including decreased IL-13 and IL-33, and reduced frequencies of IL-13-producing ILC2, Th2 cells, and basophils in the lung [105]
The SUSTAIN 29,30,31,32,33,34,35 and SCALE studies 10,11,12,13,14,15 have shown robust efficacy in lowering blood glucose levels in diabetic patients and inducing weight loss in obese patients over clinical trial periods ranging from 30 to 104 weeks
All protocols are individualized: these ranges are not a standard or approved regimen
Evidence supports that a low-fat, low-carb, plant-based dietary intervention is suitable for gouty patients
Mojsov S, Weir GC, Habener JF
Excluding Shapiro (2025) yielded a pooled log RR of 0.287 (95% CI: 0.0180.557)